← Back
Data updated: Mar 10, 2026
SPERTI
Pharmaceuticals
SPERTI is a generic drug manufacturer with 2 FDA-approved products.
1973
Since
2
Drugs
-
Trials
67
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PREDNISONE 2025-10-01
PREDNISOLONE 2025-06-23
PREDNISOLONE 2025-02-13
Manufacturing (CMC)
PREDNISOLONE 2024-07-22
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-07
Labeling
PREDNISONE 2024-06-05
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (2)
Company Info
- First Approval
- 1973-05-01
- Latest
- 1973-05-01
- Applications
- 2